In an early human trial, Eli Lilly’s eloralintide helped people lose up to 20% of their body...
obesity
Auto Added by WPeMatico
New research suggests that people taking GLP-1 therapy are less likely to die from colorectal cancer.
New research continues to show that many people meet the criteria for obesity and associated health problems,...
Severe diverticulitis is becoming a bigger issue for people under 50.
New research finds that the reported rise in many cancers isn’t just limited to younger adults.
New research shows that substantially more Americans would qualify as being obese using new diagnostic criteria released...
The study, published last year, was found to contain unreliable and “implausible” data.
Semaglutide and tirzepatide are among 20 new additions to the WHO’s list of essential medicines.
In new Phase III trial data released Tuesday, people taking orforglipron lost substantially more weight than people...
The Danish pharmaceutical company has struggled in recent months to meet its lofty sales expectations.
